Marimed (MRMD) Proxy Filing summary

Executive summary

• Annual Meeting scheduled for June 12, 2025, to elect four directors and approve independent auditors for 2025.

• Record date for voting is April 15, 2025, with 393,618,010 votes eligible to be cast.

• Proxy materials, including the annual report, are available online and by mail.

Voting matters and shareholder proposals

• Proposals include election of four directors and advisory approval of M&K CPAs PLLC as independent auditors for 2025.

• Shareholders may submit proposals and director nominations for the 2026 meeting within specified deadlines.

• Proxy access and universal proxy rules are outlined for shareholder nominations.

Board of directors and corporate governance

• Board will be reduced to four members after the meeting; all nominees are current directors.

• Board committees: Audit, Compensation, and Nominating & Governance, all comprised of independent directors.

• Board leadership structure features a non-executive chairman and separate CEO.

• Code of Ethics applies to all directors, officers, and employees.

• Directors encouraged to attend annual meetings; all attended in 2024.